Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Clinical Rx -
--->News
[-]The Project
--->Sponsor
--->[+]Executive Committee
--->[+]Writing Committee Strategic ...
--->[+]Scientific and Bioethics Advis...
--->Central Coordination
--->Language Coordination
--->Fellowship Programme
--->[+]Constitution
--->[+]Voting/Nomination
--->[-]Members
--->Request
[+]Locations
[-]Working Groups
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[+]Young Adults
[-]Events
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[+]Communication
--->Job Offers
datedescriptionsizeauthor document 
03.08.26Multivariate classification of central nervous system-acting drugs based on in vivo response patterns – profile of pridopidine32 kBanonymousapplication/mswordq06-multivariate-classification-centra... 
03.08.26Long-term safety and tolerability of pridopidine in patients with Huntington’s Disease (HD): results of the MermaiHD study open-label extension32 kBanonymousapplication/mswordq07-long-term-safety-and-tolerability-... 
03.08.26Potential neuroprotective effects of pridopidine in Huntington’s Disease32 kBanonymousapplication/mswordq08-potential-neuroprotective-effects-... 
03.08.26Valproic Acid for the treatment of aggressiveness in Huntington’s disease: one year follow-up32 kBanonymousapplication/mswordq09-valproic-acid 
03.08.26Adverse effects of antipsychotics and antidepressants in advanced HD: four cases in a skilled nursing facility32 kBanonymousapplication/mswordq05-adverse-effects-of-antipsychotics-... 
03.08.26Impact of Tetrabenazine on balance and gait in individuals with Huntington’s Disease32 kBanonymousapplication/mswordq04-impact-of-tetrabenazine 
03.08.26SirT1 mediated modulation of circulating cytokines in Huntington’s Disease - pharmacodynamics results from Phase 1b study of Selisistat - a SirT1 inhibitor32 kBanonymousapplication/mswordq01-sirt1-mediated-modulation 
03.08.26A randomized, double-blind, placebo-controlled Phase Ib pharmacodynamic study with Selisistat (SEN0014196) in HD patients32 kBanonymousapplication/mswordq02-sen0014196 
03.08.26Effects of Tetrabenazine on choreiform movements in the ransgenic rat model of Huntington’s Disease32 kBanonymousapplication/mswordq03-effects-of-tetrabenazine 
03.08.26ACTION-HD: A randomized, double-blind, placebo-controlled prospective crossover trial investigating the efficacy and safety of bupropion in Huntington’s Disease32 kBanonymousapplication/mswordq10-action-hd 
03.08.26A randomised feasibility study of a 12-week exercise programme in Huntington’s disease (HD)32 kBanonymousapplication/mswordq12-randomised-feasibility-study 
03.08.26Music therapy as a method to improve the quality of life of patients with Huntington’s Disease – preliminary findings32 kBanonymousapplication/mswordq18-music-therapy 
03.08.26Intensive rehabilitation for Huntington's Disease: a qualitative study of participants' and health professionals' experiences32 kBanonymousapplication/mswordq19-intensive-rehab-hd 
03.08.26A multidisciplinary intensive rehabilitation program for persons with Huntington's Disease: Results after one year32 kBanonymousapplication/mswordq20-rehabilitation-program-results 
03.08.26A rehabilitation centers multidisciplinary approach to treatment of HD-patients32 kBanonymousapplication/mswordq21-rehabilitation-centers 
03.08.26Psychomotor therapy and the training of relaxation skills in dealing with chorea and stress32 kBanonymousapplication/mswordq17-psychomotor-therapy 
03.08.26Exercises for self-perception as an alternative type of physiotherapeutic practice increase motivation for other therapeutic interventions in HD32 kBanonymousapplication/mswordq16-exercises-for-self-perception 
03.08.26Perspectives of participating in a 12 week exercise programme for people with early -mid stage Huntington's Disease32 kBanonymousapplication/mswordq13-perspectives-of-participating-in-1... 
03.08.26Sub maximal exercise testing in people with early stage Huntington's Disease32 kBanonymousapplication/mswordq14-sub-maximal-exercise-testing 
03.08.26A pilot study of an exercise intervention to improve motor function in people with Huntington’s disease (HD)32 kBanonymousapplication/mswordq15-pilot-study-exercise-intervention 
03.08.26Study of the suitability of a garden for use by clients with Huntington's Disease, relatives and staff for therapy and leisure gardening32 kBanonymousapplication/mswordq22-gardening 

Folder contains 21 documents.
about us | privacy statement | disclaimer | terms of use